Renal Dialysis Clinical Trial
— BalanceWise-HDOfficial title:
Intervention to Reduce Dietary Sodium in Hemodialysis
Verified date | August 2017 |
Source | University of Pittsburgh |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to test, in a randomized clinical trial of 200 hemodialysis patients, a behavioral intervention to reduce dietary sodium intake. The investigators will assess the impact on weight gain between dialysis treatments, blood pressures, symptoms, and health-related quality of life. The primary study hypotheses are that participants will gain less weight in between dialysis treatments, and that dietary recalls will demonstrate reduced consumption of dietary sodium.
Status | Completed |
Enrollment | 179 |
Est. completion date | September 2012 |
Est. primary completion date | September 2012 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Individuals with end stage renal disease (ESRD) who are 18 years of age or older, - Individuals who are literate, - Community-dwelling adults who have been receiving maintenance dialysis for at least 3 months. Exclusion Criteria: - Individuals who cannot read or write, - Individuals who do not speak English, - Individuals who plan to move out of the area or change dialysis centers within the next 6 months, - Individuals who have a life expectancy of less than 12 months, - Individuals who are scheduled for a living donor transplant, - Individuals who cannot see the PDA screen or use the stylus to make food selections from the PDA screen, or - Individuals who live in an institutional setting in which they would have limited control over their dietary intake. |
Country | Name | City | State |
---|---|---|---|
United States | University of Pittsburgh School of Medicine | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
University of Pittsburgh | National Institute of Nursing Research (NINR), University of Iowa |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time Specific Interdialytic Weight Gain (Baseline) | Average interdialytic weight gains (kg/day) were calculated for the 1 week period prior to baseline measurement. | Baseline | |
Primary | Time Specific Interdialytic Weight Gain (8 Weeks) | Average interdialytic weight gains (kg/day) were calculated for the 1 week period prior to the 8-week measurement time point. | 8 weeks | |
Primary | Time Specific Interdialytic Weight Gain (12 Weeks) | Average interdialytic weight gains (kg/day) were calculated for the 1 week period prior to the 12 week measurement time point. | 12 weeks | |
Primary | Time Specific Interdialytic Weight Gain (16 Weeks) | Average interdialytic weight gains (kg/day) were calculated for the 1 week period prior to the 16 week measurement time point. | 16 weeks | |
Primary | Time Specific Dietary Sodium Intake (Baseline) | Dietary sodium intake was assessed via three 24-hour dietary recalls, including 1 dialysis weekday, 1 non-dialysis weekday, and 1 non dialysis weekend day. Recalls were entered into Nutrition Data System for Research, with sodium intake averaged across the 3 recalls. | Baseline | |
Primary | Time Specific Dietary Sodium Intake (8 Weeks) | Dietary sodium intake was assessed via three 24-hour dietary recalls, including 1 dialysis weekday, 1 non-dialysis weekday, and 1 non dialysis weekend day. Recalls were entered into Nutrition Data System for Research, with sodium intake averaged across the 3 recalls. | 8 weeks | |
Primary | Time Specific Dietary Sodium Intake (16 Weeks) | Dietary sodium intake was assessed via three 24-hour dietary recalls, including 1 dialysis weekday, 1 non-dialysis weekday, and 1 non dialysis weekend day. Recalls were entered into Nutrition Data System for Research, with sodium intake averaged across the 3 recalls. | 16 weeks | |
Primary | Time Specific Change From Baseline in Dietary Sodium Intake (Baseline to 8 Weeks) | Dietary sodium intake was assessed via three 24-hour dietary recalls, including 1 dialysis weekday, 1 non-dialysis weekday, and 1 non dialysis weekend day. Recalls were entered into Nutrition Data System for Research, with sodium intake averaged across the 3 recalls. The difference between measurement time points was determined. | Baseline to 8 weeks | |
Primary | Time Specific Change From Baseline in Dietary Sodium Intake (Baseline to 16 Weeks) | Dietary sodium intake was assessed via three 24-hour dietary recalls, including 1 dialysis weekday, 1 non-dialysis weekday, and 1 non dialysis weekend day. Recalls were entered into Nutrition Data System for Research, with sodium intake averaged across the 3 recalls. | Baseline to 16 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05189795 -
The Construction of Physical ACtivity Enhancement Scheme (PACES) in Hemodialysis Patients
|
||
Completed |
NCT00753116 -
Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension
|
Phase 1 | |
Completed |
NCT00806130 -
Health Related Quality of Life and Cognitive Function Among Norwegian Dialysis Patients
|
||
Completed |
NCT00730145 -
A Single Dose Study Investigating The Elimination Of PD-0332334 In Patients Receiving Regular Hemodialysis
|
Phase 1 | |
Completed |
NCT05718765 -
The Effect of Physical ACtivity Enhancement Scheme (PACES) in Hemodialysis Patients
|
N/A | |
Completed |
NCT03250715 -
Effects of Low Level Laser Therapy on Functional Capacity and DNA Damage of Patients With Chronic Kidney Failure
|
N/A | |
Completed |
NCT05469620 -
Adaptive Nutrition Therapy in Hemodialysis
|
N/A | |
Completed |
NCT03536858 -
Social Networks and Renal Education: Promoting Transplantation
|
N/A | |
Completed |
NCT00824837 -
Study of beta2-Microglobulin Removal by Standard Versus New High Cut-Off Haemodialysis Membrane
|
Phase 1/Phase 2 | |
Completed |
NCT03403491 -
Study of Self-monitoring of Weight & Blood Pressure (Via patientMpower Platform) in Hemodialysis
|
N/A | |
Terminated |
NCT02495662 -
The LIPMAT Study: Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation
|
Phase 2 | |
Completed |
NCT01179620 -
Certoparin in Renal Patients Undergoing Hemodialysis
|
Phase 3 | |
Completed |
NCT01017276 -
A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis
|
Phase 3 | |
Active, not recruiting |
NCT04466865 -
A Communication Tool to Assist Older Adults Facing Dialysis Choices
|
N/A | |
Recruiting |
NCT03782519 -
Quality of Life of Frail Aged Patients in Incremental Hemodialysis
|
N/A | |
Recruiting |
NCT02843334 -
Study of the Prevalence of Fabry Disease in French Dialysis Patients
|
N/A | |
Recruiting |
NCT02545530 -
Transdermal Clonidine in Chronic Hemodialysis Patients
|
N/A | |
Completed |
NCT00892749 -
Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
|
Phase 3 | |
Completed |
NCT00649298 -
A Clinical Trial of IntensiVE Dialysis
|
Phase 4 | |
Completed |
NCT05833451 -
Reiki in Symptom Management of Hemodialysis Patients
|
N/A |